Inaktiver Wert

Andere Sprachen Mirati Therapeutics

Aktien

A1W1XV

US60468T1051

MRTX

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

British billionaire Joe Lewis intends to plead guilty to US charges, lawyer says	24.01.
Mirati Therapeutics, Inc.(NasdaqGS:MRTX) dropped from S&P Biotechnology Select Industry Index	24.01.
Mirati Therapeutics, Inc.(NasdaqGS:MRTX) dropped from S&P TMI Index	24.01.
Mirati Therapeutics, Inc.(NasdaqGS:MRTX) dropped from S&P Global BMI Index	24.01.
Bristol-Myers Squibb Closes Acquisition of Mirati Therapeutics	23.01.
Bristol-Myers Squibb Closes Mirati Therapeutics Acquisition	23.01.
Bristol Myers : acquisition de Mirati Therapeutics finalisée	23.01.
Mirati Therapeutics, Inc. Announces Management Changes	23.01.
Mirati Therapeutics, Inc.(NasdaqGM:MRTX) dropped from NASDAQ Composite Index	23.01.
Bristol-Myers Squibb Company completed the acquisition of Mirati Therapeutics, Inc. from a group of shareholders.	23.01.
Mirati Therapeutics, Inc.(NasdaqGS:MRTX) dropped from NASDAQ Biotechnology Index	22.01.
Mirati Therapeutics - European Commission Approves KRAZATI as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer with a KRASG12C Mutation	11.01.
Mirati Therapeutics' Krazati Lung Cancer Treatment Gets EU Conditional Marketing Authorization	10.01.
European Commission Approves KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation	10.01.
Bristol Myers expects to launch 16 new products through 2030 - CEO	08.01.
Immunome Appoints Phil Roberts as Chief Technical Officer	04.01.
Bristol-Myers Squibb koopt RayzeBio	26.12.
US FDA turns down Amgen lung cancer drug Lumakras for full approval	26.12.
Bristol-Myers Agrees Deal to Buy RayzeBio for About $4.1 Billion	26.12.
Bristol Myers comprará a Karuna Therapeutics por 14.000 millones de dólares	22.12.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Mirati Therapeutics

Aktien

A1W1XV

US60468T1051

MRTX

Andere Sprachen

Filter